Antoine Awad
Plus aucun poste en cours
Fortune : 62 978 $ au 30/04/2024
Historique de carrière de Antoine Awad
Anciens postes connus de Antoine Awad
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SYNLOGIC, INC. | Directeur Général | 18/03/2024 | 30/05/2024 |
| Directeur des opérations | 30/07/2020 | 18/03/2024 | |
| Directeur Technique/Scientifique/R&D | 01/10/2018 | 30/07/2020 | |
| Corporate Officer/Principal | 01/10/2018 | - | |
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
L.E.A.F. Pharmaceuticals LLC
 L.E.A.F. Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology L.E.A.F. Pharmaceuticals LLC engages in a pharmaceuticals company. It develops and commercializes therapies for cancer, autoimmune, and infectious diseases. The company was founded by Clet Niyikiza and is headquartered in Woburn, MA. | Corporate Officer/Principal | - | - |
| ABPRO CORPORATION | Directeur des opérations | - | - |
Formation de Antoine Awad
| Boston University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Israël | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SYNLOGIC, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
L.E.A.F. Pharmaceuticals LLC
L.E.A.F. Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology L.E.A.F. Pharmaceuticals LLC engages in a pharmaceuticals company. It develops and commercializes therapies for cancer, autoimmune, and infectious diseases. The company was founded by Clet Niyikiza and is headquartered in Woburn, MA. | Health Technology |
- Bourse
- Insiders
- Antoine Awad
- Expérience
